Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Medtech Innovation On Advanced Medicine S L U manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This application is assigned to 1 distinct art unit and 1 distinct examiner, which shows that the company's current patent activity is limited to a single technical review group. This concentration allows the applicant to focus its resources on meeting the specific requirements of one specialized section of the patent office rather than navigating multiple administrative frameworks.
The busiest examiner for the portfolio is MCCORMICK, CATHERINE LYNN, who is responsible for 1 pending office action. Because this examiner is the only individual handling the current pending workload, their specific interpretation of the prior art and claim construction will be the determining factor in the prosecution outcome. Practitioners should evaluate the examiner's past decisions within the Biotechnology & Pharmaceuticals sector to anticipate potential hurdles. Tailoring responses to the examiner's established review patterns can help optimize the path toward allowance for this pending application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCORMICK, CATHERINE LYNN | 1 | 52.3% | +39.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17799847 | SYSTEM FOR STORING AND TRANSPORTING CELL LINES | MCCORMICK, CATHERINE LYNN | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17799847 | SYSTEM FOR STORING AND TRANSPORTING CELL LINES | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | — | Pending | Aug 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMedtech Innovation On Advanced Medicine S L U has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Catherine Lynn Mccormick has the most, with 1 of Medtech Innovation On Advanced Medicine S L U's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
